Zydus Lifesciences has had a strong 9MFY25 reporting a revenue and earnings growth of 19 per cent and 26 per cent, respectively, year on year. The US market, accounting for half the revenues, led wit… [+5569 chars]...
Read moreApr 19, 2025, 11:06:51 AM IST The largest fund house had an AUM of Rs 10.67 lakh crore in March and had an equity AUM of Rs 7.39 lakh crore in the same period. The fund house manages 50 equity schem… [+1356 chars]...
Read moreNEW DELHI: The Nifty Pharma index closed on a positive note on Monday. Shares of Lupin Ltd.(up 4.25 per cent), Ajanta Pharma Ltd.(up 3.71 per cent), Glenmark Pharmaceuticals Ltd.(up 3.45 per cent), Z… [+1097 chars]...
Read moreNEW DELHI: The Nifty Pharma index traded positive around 11:05AM(IST)on Wednesday in an upbeat market. Lupin Ltd.(up 2.22 per cent), Alkem Laboratories Ltd.(up 1.89 per cent), Torrent Pharmaceuticals… [+1167 chars]...
Read moreShares of Bajaj Finance, Tata Consumer Products, HDFC Bank, Axis Bank and Shriram Finance traded among major gainers, while ONGC, Hindalco, Tata Steel, Tata Motors and Cipla dragged among Nifty 50 co… [+1801 chars]...
Read moreZydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to manufacture the generic version of cholesterol lowering Niacin extended-release tablets. The ap… [+1003 chars]...
Read more